Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Director · Ovid Therapeutics Inc. · Common Stock
Grant or award — administrative, little informational value
$45K reported value · new position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Greka AnnaDirector | Grant or award | A | — 130.0K sh | Jun 17, 2026 traded Jun 15, 2026 | |
| 31 | Alexander Margaret A.Director, President and CEO | Open-market sale | SELL | $17K 11.7K sh | Mar 2, 2026 traded Feb 23, 2026 | |
| 5 | Alexander Margaret A.Director, President and CEO | Grant or award | A | — 1.44M sh | Mar 2, 2026 traded Feb 26, 2026 | |
| 9 | Alexander Margaret A.Director, President and CEO | Grant or award | A | — 890.0K sh | Jan 5, 2026 traded Jan 4, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $45,000
Fitzgerald Kevin Joseph filed this Form 4 reporting a grant or award of OVID on Apr 7, 2026. It became public on Apr 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.